Global Information
회사소개 | 문의 | 비교리스트

세계의 당생물학(Glycobiology) 시장 : 예측과 기회(-2025년)

Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934749
페이지 정보 영문 116 Pages
가격
US $ 4,450 ₩ 5,070,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,209,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,767,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 당생물학(Glycobiology) 시장 : 예측과 기회(-2025년) Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 116 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 당생물학(Glycobiology) 시장은 예측기간 동안 놀라운 속도로 성장할 것으로 예상됩니다. 세계 당생물학 시장은 암, 당뇨병, 신장질환 등의 만성질환 유병률 증가에 힘입어 성장하고있으며, 맞춤형 의료 수요가 증가하고 있습니다. 이로 인해 전세계 신약 개발 프로세스가 증가하고, 예측기간 동안 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

세계의 당생물학(Glycobiology) 시장을 부문별/지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 코로나19(COVID-19)가 세계 당생물학 시장에 미치는 영향

제4장 개요

제5장 고객의 견해

  • 브랜드 인지도
  • 제품 인식
  • 고객 만족도 분석
  • 충족되지 않은 욕구와 과제

제6장 세계의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별(Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases 등)
    • 키트 종류별(Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification 등)
    • 용도별(신약 개발, 질병 진단, 바이러스학, 세포생물학, 종양학 등)
    • 최종사용자별(조사기관, 진단센터, 병원, 임상 실험실, 제약/바이오 기업 등)
    • 기업별(2019년)
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별
    • 키트 종류별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제8장 유럽의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별
    • 키트 종류별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별
    • 키트의 유형별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별
    • 키트 종류별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 당생물학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 효소 종류별
    • 키트 종류별
    • 용도별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 경쟁 상황

  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics SL
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R & D Systems, Inc.
  • Bio-Techne
  • Danaher Corporation
  • S-BIO(subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • ProZyme

제15장 전략적 권장사항

제16장 면책조항

LSH 20.06.05

Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years.

The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on type of enzyme, the market can be categorized into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is expected to dominate the market during the forecast period. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the global glycobiology market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global glycobiology market from 2015 to 2018.
  • To estimate and forecast the market size of global glycobiology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global glycobiology market based on type of enzyme, type of kit, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global glycobiology market.
  • To identify drivers and challenges for global glycobiology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global glycobiology market.
  • To identify and analyze the profile of leading players operating in global glycobiology market.
  • To identify key sustainable strategies adopted by market players in global glycobiology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global glycobiology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global glycobiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Glycobiology Market, By Type of Enzyme:

Glycosidases & Neuramidases

Glycosyltransferases & Sialytransferases

Carbohydrate Kinases

Carbohydrate Sulfotransferases

Protein Sulfotransferases

Others

  • Global Glycobiology Market, By Type of Kit:

Glycan Releasing Kit

Glycan Labelling Kit

Glycan Purification Kit

Others

  • Global Glycobiology Market, By Application:

Drug Discovery

Disease Diagnostics

Virology

Cell Biology

Oncology

Others

  • Global Glycobiology Market, By End User:

Research Institutes

Diagnostic Centers

Hospitals

Clinical Laboratories

Pharmaceutical & Biotechnology Companies

Others

  • Global Glycobiology Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global glycobiology market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global Glycobiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
    • 6.2.2. By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
    • 6.2.3. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
    • 6.2.4. By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Glycobiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Enzyme
    • 7.2.2. By Type of Kit
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Glycobiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Enzyme
        • 7.3.1.2.2. By Type of Kit
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. India Glycobiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Enzyme
        • 7.3.2.2.2. By Type of Kit
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Glycobiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Enzyme
        • 7.3.3.2.2. By Type of Kit
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Glycobiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Enzyme
        • 7.3.4.2.2. By Type of Kit
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Glycobiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Enzyme
        • 7.3.5.2.2. By Type of Kit
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Europe Glycobiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Enzyme
    • 8.2.2. By Type of Kit
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Glycobiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Enzyme
        • 8.3.1.2.2. By Type of Kit
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Glycobiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Enzyme
        • 8.3.2.2.2. By Type of Kit
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Glycobiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Enzyme
        • 8.3.3.2.2. By Type of Kit
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Glycobiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Enzyme
        • 8.3.4.2.2. By Type of Kit
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Glycobiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Enzyme
        • 8.3.5.2.2. By Type of Kit
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. North America Glycobiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Enzyme
    • 9.2.2. By Type of Kit
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Glycobiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Enzyme
        • 9.3.1.2.2. By Type of Kit
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Glycobiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Enzyme
        • 9.3.2.2.2. By Type of Kit
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Glycobiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Enzyme
        • 9.3.3.2.2. By Type of Kit
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Glycobiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Enzyme
    • 10.2.2. By Type of Kit
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Glycobiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Enzyme
        • 10.3.1.2.2. By Type of Kit
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Glycobiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Enzyme
        • 10.3.2.2.2. By Type of Kit
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Glycobiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Enzyme
        • 10.3.3.2.2. By Type of Kit
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Glycobiology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Enzyme
    • 11.2.2. By Type of Kit
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Glycobiology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type of Enzyme
        • 11.3.1.2.2. By Type of Kit
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Glycobiology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type of Enzyme
        • 11.3.2.2.2. By Type of Kit
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Glycobiology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type of Enzyme
        • 11.3.3.2.2. By Type of Kit
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Kuwait Glycobiology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type of Enzyme
        • 11.3.4.2.2. By Type of Kit
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co., Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Thermo Fisher Scientific
  • 14.4. New England Biolabs, Inc.
  • 14.5. Shimadzu Corporation
  • 14.6. Takara Bio Inc.
  • 14.7. Waters Corporation
  • 14.8. Asparia Glycomics S.L.
  • 14.9. Bruker Corporation
  • 14.10. RayBiotech, Inc.
  • 14.11. Z Biotech, LLC.
  • 14.12. Chemily Glycoscience
  • 14.13. Dextra Laboratories Ltd.
  • 14.14. Lectenz Bio
  • 14.15. Ludger Ltd
  • 14.16. R&D Systems, Inc.
  • 14.17. Bio-Techne
  • 14.18. Danaher Corporation
  • 14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • 14.20. ProZyme

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q